BCM
DPLO

Bridgeway Capital Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Bridgeway Capital Management’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-13,400
Closed -$375K – 1476
2016
Q3 		$375K Sell
13,400
-2,000
-13% -$67.1K 0.01% 1186
2016
Q2 		$539K Sell
15,400
-95,300
-86% -$3M 0.01% 1016
2016
Q1 		$3.03M Sell
110,700
-1,800
-2% -$53K 0.05% 354
2015
Q4 		$3.85M Buy
112,500
+65,800
+141% +$2.05M 0.07% 282
2015
Q3 		$1.34M Buy
+46,700
New +$2M 0.03% 610

Other funds holding DPLO

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
HIM
Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Bridgeway Capital Management's DPLO Position: Q4 2016 in Review

Bridgeway Capital Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q4 2016, closing a stake of 13,400 shares — an estimated $375K sold.

Bridgeway Capital Management first reported a position in DPLO in Q3 2015 and held it in 5 quarters. The position peaked at $3.85M in Q4 2015. 174 funds tracked by Wall St. Rank hold DPLO as of Q4 2016.

  • Bridgeway Capital Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q4 2016 after selling out during the quarter.
  • Bridgeway Capital Management sold 13,400 DIPLOMAT PHARMACY, INC. shares in Q4 2016, an estimated $375K.
  • Bridgeway Capital Management first reported a position in DIPLOMAT PHARMACY, INC. in Q3 2015 and held it in 5 quarters.
  • Bridgeway Capital Management's DIPLOMAT PHARMACY, INC. position peaked at $3.85M in Q4 2015.
  • 174 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q4 2016.

Based on Bridgeway Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.